A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity

R. Bottinelli, D. A. Coviello, C. S. Redwood, M. A. Pellegrino, B. J. Maron, P. Spirito, H. Watkins, C. Reggiani

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Mutant contractile protein genes that cause familial hypertrophic cardiomyopathy (FHC) are presumed to encode mutant proteins that interfere with contractile function. However, it has generally not been possible to show mutant protein expression and incorporation into the sarcomere in vivo. This study aimed to assess whether a mutant α-fast tropomyosin (TM) responsible for FHC is actually expressed and determines abnormal contractile function. Since α-fast TM is expressed in heart and skeletal muscle, samples from vastus lateralis muscles were studied from two FHC patients carrying an Asp175Asn α-fast TM mutation and two healthy control subjects. TM isoforms from whole biopsy samples and single fibers were identified by gel electrophoresis and Western blot analysis. An additional faster-migrating TM band was observed in both FHC patients. The aberrant TM was identified as the Asp175Asn α-fast TM by comigration with purified recombinant human Asp175Asn α-fast TM. Densitometric quantification of mutant and wild- type α-fast TMs suggested equal expression of the two proteins. Contractile parameters of single skinned muscle fibers from FHC patients and healthy control subjects were compared. Calcium sensitivity was significantly increased in muscle fibers containing Asp175Asn α-fast Tm compared with fibers lacking the mutant TM. No discernible difference was found regarding cooperativity, maximum force, and maximum shortening velocity. This is the first demonstration that the mutant TM that causes FHC is indeed expressed and almost certainly incorporated into muscle in vivo and does result in altered contractile function; this confirms a dominant-negative, rather than null allele, action. Since the mutant TM was associated with increased calcium sensitivity, this mutation might be associated with an enhancement and not a depression of cardiac contractile performance. If so, this contrasts with the hypothesis that FHC mutations induce contractile impairment followed by compensatory hypertrophy.

Original languageEnglish
Pages (from-to)106-115
Number of pages10
JournalCirculation Research
Volume82
Issue number1
Publication statusPublished - 1998

Fingerprint

Tropomyosin
Hypertrophic Cardiomyopathy
Familial Hypertrophic Cardiomyopathy
Calcium
Mutant Proteins
Muscles
Mutation
Healthy Volunteers
Contractile Proteins
Sarcomeres
Quadriceps Muscle
Hypertrophy
Electrophoresis
Myocardium
Protein Isoforms
Skeletal Muscle
Western Blotting
Gels
Alleles

Keywords

  • Ca sensitivity
  • Familial hypertrophic cardiomyopathy
  • Skinned muscle fiber
  • Tropomyosin

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Bottinelli, R., Coviello, D. A., Redwood, C. S., Pellegrino, M. A., Maron, B. J., Spirito, P., ... Reggiani, C. (1998). A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circulation Research, 82(1), 106-115.

A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. / Bottinelli, R.; Coviello, D. A.; Redwood, C. S.; Pellegrino, M. A.; Maron, B. J.; Spirito, P.; Watkins, H.; Reggiani, C.

In: Circulation Research, Vol. 82, No. 1, 1998, p. 106-115.

Research output: Contribution to journalArticle

Bottinelli, R, Coviello, DA, Redwood, CS, Pellegrino, MA, Maron, BJ, Spirito, P, Watkins, H & Reggiani, C 1998, 'A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity', Circulation Research, vol. 82, no. 1, pp. 106-115.
Bottinelli, R. ; Coviello, D. A. ; Redwood, C. S. ; Pellegrino, M. A. ; Maron, B. J. ; Spirito, P. ; Watkins, H. ; Reggiani, C. / A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. In: Circulation Research. 1998 ; Vol. 82, No. 1. pp. 106-115.
@article{6b95eeb925574cd7b11b9e0f8e983329,
title = "A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity",
abstract = "Mutant contractile protein genes that cause familial hypertrophic cardiomyopathy (FHC) are presumed to encode mutant proteins that interfere with contractile function. However, it has generally not been possible to show mutant protein expression and incorporation into the sarcomere in vivo. This study aimed to assess whether a mutant α-fast tropomyosin (TM) responsible for FHC is actually expressed and determines abnormal contractile function. Since α-fast TM is expressed in heart and skeletal muscle, samples from vastus lateralis muscles were studied from two FHC patients carrying an Asp175Asn α-fast TM mutation and two healthy control subjects. TM isoforms from whole biopsy samples and single fibers were identified by gel electrophoresis and Western blot analysis. An additional faster-migrating TM band was observed in both FHC patients. The aberrant TM was identified as the Asp175Asn α-fast TM by comigration with purified recombinant human Asp175Asn α-fast TM. Densitometric quantification of mutant and wild- type α-fast TMs suggested equal expression of the two proteins. Contractile parameters of single skinned muscle fibers from FHC patients and healthy control subjects were compared. Calcium sensitivity was significantly increased in muscle fibers containing Asp175Asn α-fast Tm compared with fibers lacking the mutant TM. No discernible difference was found regarding cooperativity, maximum force, and maximum shortening velocity. This is the first demonstration that the mutant TM that causes FHC is indeed expressed and almost certainly incorporated into muscle in vivo and does result in altered contractile function; this confirms a dominant-negative, rather than null allele, action. Since the mutant TM was associated with increased calcium sensitivity, this mutation might be associated with an enhancement and not a depression of cardiac contractile performance. If so, this contrasts with the hypothesis that FHC mutations induce contractile impairment followed by compensatory hypertrophy.",
keywords = "Ca sensitivity, Familial hypertrophic cardiomyopathy, Skinned muscle fiber, Tropomyosin",
author = "R. Bottinelli and Coviello, {D. A.} and Redwood, {C. S.} and Pellegrino, {M. A.} and Maron, {B. J.} and P. Spirito and H. Watkins and C. Reggiani",
year = "1998",
language = "English",
volume = "82",
pages = "106--115",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity

AU - Bottinelli, R.

AU - Coviello, D. A.

AU - Redwood, C. S.

AU - Pellegrino, M. A.

AU - Maron, B. J.

AU - Spirito, P.

AU - Watkins, H.

AU - Reggiani, C.

PY - 1998

Y1 - 1998

N2 - Mutant contractile protein genes that cause familial hypertrophic cardiomyopathy (FHC) are presumed to encode mutant proteins that interfere with contractile function. However, it has generally not been possible to show mutant protein expression and incorporation into the sarcomere in vivo. This study aimed to assess whether a mutant α-fast tropomyosin (TM) responsible for FHC is actually expressed and determines abnormal contractile function. Since α-fast TM is expressed in heart and skeletal muscle, samples from vastus lateralis muscles were studied from two FHC patients carrying an Asp175Asn α-fast TM mutation and two healthy control subjects. TM isoforms from whole biopsy samples and single fibers were identified by gel electrophoresis and Western blot analysis. An additional faster-migrating TM band was observed in both FHC patients. The aberrant TM was identified as the Asp175Asn α-fast TM by comigration with purified recombinant human Asp175Asn α-fast TM. Densitometric quantification of mutant and wild- type α-fast TMs suggested equal expression of the two proteins. Contractile parameters of single skinned muscle fibers from FHC patients and healthy control subjects were compared. Calcium sensitivity was significantly increased in muscle fibers containing Asp175Asn α-fast Tm compared with fibers lacking the mutant TM. No discernible difference was found regarding cooperativity, maximum force, and maximum shortening velocity. This is the first demonstration that the mutant TM that causes FHC is indeed expressed and almost certainly incorporated into muscle in vivo and does result in altered contractile function; this confirms a dominant-negative, rather than null allele, action. Since the mutant TM was associated with increased calcium sensitivity, this mutation might be associated with an enhancement and not a depression of cardiac contractile performance. If so, this contrasts with the hypothesis that FHC mutations induce contractile impairment followed by compensatory hypertrophy.

AB - Mutant contractile protein genes that cause familial hypertrophic cardiomyopathy (FHC) are presumed to encode mutant proteins that interfere with contractile function. However, it has generally not been possible to show mutant protein expression and incorporation into the sarcomere in vivo. This study aimed to assess whether a mutant α-fast tropomyosin (TM) responsible for FHC is actually expressed and determines abnormal contractile function. Since α-fast TM is expressed in heart and skeletal muscle, samples from vastus lateralis muscles were studied from two FHC patients carrying an Asp175Asn α-fast TM mutation and two healthy control subjects. TM isoforms from whole biopsy samples and single fibers were identified by gel electrophoresis and Western blot analysis. An additional faster-migrating TM band was observed in both FHC patients. The aberrant TM was identified as the Asp175Asn α-fast TM by comigration with purified recombinant human Asp175Asn α-fast TM. Densitometric quantification of mutant and wild- type α-fast TMs suggested equal expression of the two proteins. Contractile parameters of single skinned muscle fibers from FHC patients and healthy control subjects were compared. Calcium sensitivity was significantly increased in muscle fibers containing Asp175Asn α-fast Tm compared with fibers lacking the mutant TM. No discernible difference was found regarding cooperativity, maximum force, and maximum shortening velocity. This is the first demonstration that the mutant TM that causes FHC is indeed expressed and almost certainly incorporated into muscle in vivo and does result in altered contractile function; this confirms a dominant-negative, rather than null allele, action. Since the mutant TM was associated with increased calcium sensitivity, this mutation might be associated with an enhancement and not a depression of cardiac contractile performance. If so, this contrasts with the hypothesis that FHC mutations induce contractile impairment followed by compensatory hypertrophy.

KW - Ca sensitivity

KW - Familial hypertrophic cardiomyopathy

KW - Skinned muscle fiber

KW - Tropomyosin

UR - http://www.scopus.com/inward/record.url?scp=0031883848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031883848&partnerID=8YFLogxK

M3 - Article

VL - 82

SP - 106

EP - 115

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -